Holden Thorp became provost and executive vice chancellor for Academic Affairs at Washington University in St. Louis on July 1, 2013. He is the Rita Levi-Montalcini Distinguished University Professor and holds appointments in both chemistry and medicine.
In his research career, Thorp developed technology for electronic DNA chips and co-founded Viamet Pharmaceuticals and Innocrin Pharmaceuticals, which are commercializing new drugs for fungal disease and prostate cancer, respectively. Thorp is currently a member of the the boards of the College Advising Corps, the National Humanities Center, the St. Louis Symphony Orchestra, and Barnes-Jewish Hospital.
For more information, visit the Office of the Provost.